Glympse Bio
Latest round
- Series B
Last raised
- May 2020
Total raised
- $52M
Investors
- 15
About Glympse Bio
Glympse Bio, Inc.Founded in 2015 and headquartered in Cambridge, US, Glympse Bio, Inc. focuses on delivering advanced diagnostic technologies.Glympse Bio offers a suite of diagnostics solutions designed to monitor disease progression through innovative biomarker technologies. Their primary target customers include healthcare providers and researchers interested in enhancing patient monitoring capabilities.Glympse Bio's revenue model is centered around product sales and partnerships within the healthcare sector. The company generates income through the sale of diagnostic products, with additional revenue streams arising from collaborations with healthcare institutions and research organizations.Looking ahead, Glympse Bio plans to introduce new diagnostic products aimed at expanding their clinical applications by the end of 2024. The company is also targeting expansion into international markets in Asia and Europe to increase its market presence.
Who invested in Glympse Bio
15 investors across 2 rounds
See all investors in Glympse Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Glympse Bio
Who invested in Glympse Bio?
Glympse Bio has 15 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Glympse Bio raised?
Glympse Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Glympse Bio last raise money?
Glympse Bio's most recent round on record is a Series B, in May 2020.
What does Glympse Bio do?
Glympse Bio is a biotechnology company.
Where is Glympse Bio headquartered?
Glympse Bio is headquartered in Cambridge, US.
Which VCs invest in companies like Glympse Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Glympse Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Glympse Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.